Current Issue
Volume: 122
Number: 4
Index: July 2010
Clinical Focus: Neurological disorders and depression
Call For Papers
September 2010
Clinical Focus: ADHD, Allergies, Immunization, and Diabetes
  • Attention-deficit/hyperactivity disorder:
    • ADHD
      • Treating children, adolescents, and adults
      • Pharmacotherapy options
      • Switching medication dosages
      • Treating ADHD in patients with concomitant disorders
      • Clinical trial developments
    • Oppositional defiant disorder
  • Immunization and pediatrics:
    • Vaccinations for infants, children, and adults:
      • HPV
      • Meningococcal
      • Influenza
    • Physical examinations for back-to-school
    • Allergy medications
    • Treating asthma in children and adolescents
  • Diabetes:
    • Juvenile diabetes
    • New drug developments for type 1 and type 2 diabetes
    • Pen devices
    • Managing diabetes in patients with concomitant disorders:
      • Obesity
      • Metabolic syndrome
      • Cardiovascular disease
      • Chronic kidney disease
      • Hypertension
    • Clinical trials, DPP-4 inhibitors, and investigational drugs
    • Diabetes in different patient populations:
      • African Americans
      • Hispanics
    • Diabetic complications:
      • Hypoglycemia
      • Macrovascular
      • Nephropathy Ocular
Submission deadline: August 02
Fast-Track deadline: August 10
About
Fast-Track peer review is available for those papers requiring immediate review (for an additional fee). Complete peer review is finalized in 1-2 weeks and comments are provided to the author within 72 hours of their receipt by the editorial office. Authors are asked to submit a revised manuscript within 10-12 days. Accepted manuscripts are processed within 2-3 weeks, published online within 3 business days of final author approval, and in print in the next available issue.
Submissions
*NEW* Submit your FAST-TRACK manuscript online today. It's fast, it's easy! Just follow the detailed instructions, fill in all the required fields, and upload your manuscript.
Get started NOW!
Contacts
Libraries:
sitelicenses@postgradmed.com

Reprints:
reprints@postgradmed.com

Subscriptions:
subscriptions@postgradmed.com

Supplements:
supplements@postgradmed.com

Document Delivery Services 1946-2010:
documentdelivery@postgradmed.com

Editorial:
editor-in-chief@postgradmed.com editorial@postgradmed.com

Website:
support@postgradmed.com

Managing Director:
John Elduff
Phone: 610-889-3732
Fax: 1-866-297-3168
j.elduff@postgradmed.com

General Information
Phone: 610-889-3730
Fax: 1-866-297-3168
1235 Westlakes Drive
Suite 320
Berwyn, PA 19312
September 8, 2010
Index - Table of Content - Article Abstract
Advertisement image
doi: 10.3810/pgm.2010.05.2145
Postgraduate Medicine: Volume 122: No.3
A Review of Insulin Pen Devices
Emily K. McCoy, PharmD And Bradley M. Wright, PharmD, BCPS
Abstract: Optimization of glycemic control is a fundamental aspect of diabetes management, and rates of diabetes-related microvascular complications are significantly decreased when glycemic control is improved. Currently, > 5 million Americans require insulin therapy to manage their diabetes, and this number is expected to multiply as the prevalence of type 2 diabetes increases secondary to several factors. The distinct pharmacodynamic properties of each insulin product help physicians decide which type of insulin is the most appropriate for each patient. The method of delivery that will ensure both patient and provider satisfaction must also be carefully considered. Insulin pen devices are designed to provide a convenient and easy means of insulin administration for the patient and can be divided into 2 categories: the reusable, durable pen, and the disposable, prefilled pen. These insulin pen devices are an alternative to the traditional insulin vial-and-syringe method and offer many advantages. Insulin pens have also been found to be less painful than the vial-and-syringe method and are often associated with greater patient preference and social acceptability. As a result, this method of insulin delivery may ultimately help to improve glycemic control and should be considered when prescribing insulin products.

Keywords: diabetes; insulin; insulin pen device; vial and syringe

(read)

Back to the table of contents for the May 2010 issue